Results 221 to 230 of about 62,929 (281)

EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013

European Urology, 2014
Vsevolod Matveev, , Axel Heidenreich
exaly   +2 more sources

Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer

European Urology, 2017
Maria J Ribal, Virginia Hernández, Thierry Lebret   +2 more
exaly   +2 more sources

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

European Urology, 2013
Morgan Roupret, Eva Comperat, Shahrokh Shariat   +2 more
exaly   +2 more sources

Eau

Revue Juridique de l'Environnement, 2015
Sironneau Jacques. Eau. In: Revue Juridique de l'Environnement, n°3, 2015. pp. 543-552.
Touzot, Charlotte, Emmanouilidou, Pantelina   +1 more
  +9 more sources

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.

European Urology, 2020
OBJECTIVE To present a summary of the 2020 version of the European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR ...
N. Mottet, R. V. D. van den Bergh, E. Briers, T. Van den Broeck, M. Cumberbatch, M. De Santis, S. Fanti, N. Fossati, G. Gandaglia, S. Gillessen, N. Grivas, J. Grummet, A. Henry, T. H. van der Kwast, T. Lam, M. Lardas, M. Liew, M. Mason, Lisa Moris, D. Oprea-Lager, H. G. van der Poel, O. Rouvière, I. Schoots, D. Tilki, T. Wiegel, P. Willemse, P. Cornford   +26 more
semanticscholar   +1 more source

European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel.

European Urology, 2021
BACKGROUND The European Association of Urology (EAU) prognostic factor risk groups for non-muscle-invasive bladder cancer (NMIBC) are used to provide recommendations for patient treatment after transurethral resection of bladder tumor (TURBT).
R. Sylvester, Ó. Rodríguez, V. Hernández, D. Turturica, L. Bauerová, H. M. Bruins, J. Bründl, T. H. van der Kwast, A. Brisuda, J. Rubio-Briones, M. Seles, A. Hentschel, V.R.M. Kusuma, N. Huebner, J. Cotte, L. Mertens, D. Volanis, O. Cussenot, J. D. Subiela Henríquez, E. de la Peña, F. Pisano, M. Pešl, A. G. van der Heijden, Sonja Herdegen, A. Zlotta, J. Hacek, A. Calatrava, S. Mannweiler, J. Bosschieter, D. Ashabere, A. Haitel, J. Côté, Soha El Sheikh, L. Lunelli, F. Algaba, I. Alemany, F. Soria, Willemien Runneboom, J. Breyer, J. Nieuwenhuijzen, C. Llorente, L. Molinaro, C. Hulsbergen–van de Kaa, M. Evert, L. Kiemeney, J. N'Dow, K. Plass, O. Čapoun, V. Soukup, J. Dominguez-escrig, D. Cohen, J. Palou, P. Gontero, M. Burger, R. Zigeuner, A. H. Mostafid, S. Shariat, M. Rouprêt, E. Compérat, M. Babjuk, B. V. van Rhijn   +60 more
semanticscholar   +1 more source

EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer.

European Urology, 2020
OBJECTIVE To present a summary of the 2020 version of the European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy & Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR ...
P. Cornford, R. V. D. van den Bergh, E. Briers, Thomas den Broeck, M. Cumberbatch, M. De Santis, S. Fanti, N. Fossati, G. Gandaglia, S. Gillessen, N. Grivas, J. Grummet, A. Henry, T. V. D. der Kwast, T. Lam, M. Lardas, M. Liew, M. Mason, Lisa Moris, D. Oprea-Lager, H. V. der Poel, O. Rouvière, I. Schoots, D. Tilki, T. Wiegel, P. Willemse, N. Mottet   +26 more
semanticscholar   +1 more source

Eau

Revue Juridique de l'Environnement, 2012
Tshidende Wa Mpinda Willy. Eau. In: Revue Juridique de l'Environnement, n°4, 2012. RIO+20. pp. 736-738.
  +8 more sources

Accuracy of the European Association of Urology (EAU) NMIBC 2021 scoring model in predicting progression in a large cohort of HG T1 NMIBC patients treated with BCG.

Minerva urology and nephrology, 2022
BACKGROUND Recently, the European Association of Urology Guidelines Panel updated the prognostic factor risk groups model for non-muscle-invasive bladder cancer (NMIBC) with the introduction of a new group of patients at Very high risk (VHR). Furthermore,
R. Contieri, R. Hurle, M. Paciotti, P. Casale, A. Saita, F. Porpiglia, C. Fiori, B. Barone, F. Crocetto, G. Lucarelli, G. Busetto, F. del Giudice, M. Maggi, F. Cantiello, R. Damiano, M. Borghesi, P. Bove, R. Bertolo, R. Papalia, A. Mari, S. Luzzago, F. Mistretta, F. Soria, P. Gontero, M. Marchioni, E. La Civita, D. Terracciano, G. Russo, L. Schips, S. Perdonà, V. Mirone, O. Tătaru, G. Musi, M. Vartolomei, R. Autorino, E. Montanari, O. de Cobelli, M. Ferro   +37 more
semanticscholar   +1 more source